微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.02% | -32.59% | 84.15% | 52/141 | 2.01% | 惠泰医疗 | 15.7% | 行业排名> |
| 2026-03-31 | 1.64% | -44.41% | -79.05% | 51/141 | 1.2% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 7.83% | -36.5% | 2.89% | 33/141 | 2.37% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 7.61% | -41.42% | 69.87% | 26/141 | 4.19% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 4.48% | -41.28% | 51.86% | 34/141 | 2.43% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 2.95% | -29.26% | -76.07% | 24/141 | 1.42% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 12.33% | -32.77% | -5.08% | 13/141 | 4.14% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 12.99% | -21.94% | 70.25% | 10/141 | 5.03% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 7.63% | -37.1% | 82.97% | 12/141 | 3.15% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 4.17% | -30.38% | -77.26% | 14/141 | 1.75% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 18.34% | 0.6% | 10.22% | 6/141 | 5.44% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 16.64% | -12.61% | 37.18% | 6/141 | 6.06% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 12.13% | -3.65% | 102.5% | 4/141 | 3.96% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 5.99% | -11.52% | -67.14% | 8/141 | 2.33% | 万泰生物 | 9.6% | 行业排名> |
| 2022-12-31 | 18.23% | -19.16% | -4.25% | 30/141 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 19.04% | 4.9% | 51.23% | 24/141 | 13.94% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 12.59% | 8.53% | 85.97% | 25/141 | 9.74% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 6.77% | 2.89% | -69.98% | 21/141 | 6.8% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 22.55% | 26.69% | 24.24% | 35/141 | 18.45% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 18.15% | 21.08% | 56.47% | 30/141 | 16.59% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 11.6% | 37.93% | 76.29% | 41/141 | 11.59% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 6.58% | 102.46% | -63.03% | 25/141 | 6.49% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 17.8% | -4.56% | 18.75% | 56/141 | 26.27% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 14.99% | 3.09% | 78.24% | 39/141 | 19.98% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 8.41% | -6.76% | 158.77% | 50/141 | 15.17% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 3.25% | -34.87% | -82.57% | 26/141 | 3.31% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 18.65% | 12.28% | 28.27% | 43/141 | 14.66% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 14.54% | 11.16% | 61.2% | 14/141 | 10.54% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 9.02% | 13.89% | 80.76% | 19/141 | 6.76% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 4.99% | 12.64% | -69.96% | 8/141 | 2.73% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 16.61% | 9.13% | 26.99% | 46/141 | 14.23% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 13.08% | 12.86% | 65.15% | 14/141 | 9.71% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 7.92% | 1.02% | 78.78% | 16/141 | 4.54% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 4.43% | 33.06% | -70.89% | 11/141 | 2.78% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 15.22% | -25.1% | 31.32% | 42/141 | 14.51% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 11.59% | 2% | 47.83% | 18/141 | 9.49% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 7.84% | -59.32% | 135.48% | 21/141 | 6.11% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.33% | 2% | -83.62% | 15/141 | 2.74% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 20.32% | -31.19% | -31.19% | 24/141 | 16.44% | 奥泰生物 | 76.87% | 行业排名> |